A significant reduction in pro-inflammatory molecules, including C-reactive protein (CRP), TNF- , and IL-6, was observed, indicating the inhibition of inflammatory pathways, likely at the level of immune system cells and adipocytes signaling
Precautions and Limitations While the Japanese Mounjaro recipe is generally safe, consider these points: Not a Pharmaceutical Substitute: It cannot replicate the effects of Mounjaro (tirzepatide), a GLP-1/GIP receptor agonist for diabetes and weight loss
Pricing starts at $325
Data availability The datasets used and/or analyzed during this study are available from the first and corresponding authors on reasonable request
well interpret patient-level fit once full obesity-specific datasets are published and labeled indications are known.) Who might benefit most: People who want GLP-1 benefits but prefer a pill over injections Patients who do well with GLP-1 effects but want a simpler routine Those who need a plan thats easier to maintain long-term 2) CagriSema (cagrilintide + semaglutide) GLP-1 plus amylin pathway What it is: CagriSema is a fixed-dose combination of cagrilintide (an amylin analog) plus semaglutide (GLP-1) , developed by Novo Nordisk